| NCT06021951 | Milk-Only Lactation Study to Evaluate the Concentration of Bempedoic Acid and Bempedoic Acid/Ezetimibe Fixed Combination Drug Product (FCDP) in the Breast Milk of Healthy Lactating Women | COMPLETED | PHASE4 | 2023-08-04 | 2024-03-22 | 2024-02-21 |
| NCT05694260 | A Clinical Study in Children With Heterozygous Familial Hypercholesterolemia (HeFH) Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing (CLEAR Path 1) | COMPLETED | PHASE2 | 2023-01-12 | 2025-06-04 | 2025-06-04 |
| NCT03531905 | Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C | COMPLETED | PHASE2 | 2018-05-09 | 2019-06-18 | 2019-06-18 |
| NCT03337308 | A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin Therapy | COMPLETED | PHASE3 | 2017-10-23 | 2018-07-18 | 2018-06-18 |
| NCT03193047 | Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg When Added to PCSK9 Inhibitor Therapy | COMPLETED | PHASE2 | 2017-04-07 | 2018-02-19 | 2018-01-29 |
| NCT03067441 | Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE) | COMPLETED | PHASE3 | 2017-02-03 | 2019-11-05 | 2019-11-05 |
| NCT03051100 | Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C | COMPLETED | PHASE2 | 2017-01-19 | 2017-07-05 | 2017-06-01 |
| NCT02993406 | Evaluation of Major Cardiovascular Events in Participants With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo | COMPLETED | PHASE3 | 2016-12-22 | 2022-11-07 | 2022-11-07 |
| NCT03001076 | Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C (CLEAR Tranquility) | COMPLETED | PHASE3 | 2016-11-29 | 2018-02-12 | 2018-01-11 |
| NCT02991118 | Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk | COMPLETED | PHASE3 | 2016-11-18 | 2018-08-22 | 2018-08-22 |
| NCT02988115 | Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant | COMPLETED | PHASE3 | 2016-11-16 | 2018-03-16 | 2018-03-16 |
| NCT02666664 | Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony) | COMPLETED | PHASE3 | 2016-01-21 | 2018-03-28 | 2018-02-21 |
| NCT02659397 | A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg | COMPLETED | PHASE2 | 2015-12 | 2016-07 | 2016-07 |
| NCT02178098 | Evaluation of ETC-1002 in Participants With Hypercholesterolemia and Hypertension | COMPLETED | PHASE2 | 2014-06-16 | 2015-05-22 | 2015-05-22 |
| NCT02072161 | Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin Therapy | COMPLETED | PHASE2 | 2014-03 | 2015-01 | 2015-01 |
| NCT02044627 | Single Radiolabeled Dose Study to Investigate the Absorption, Metabolism and Excretion of [14C]-ETC-1002 | COMPLETED | PHASE1 | 2013-12 | 2014-01 | 2014-01 |
| NCT01941836 | Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients | COMPLETED | PHASE2 | 2013-09 | 2014-11 | 2014-10 |
| NCT01779453 | A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With Hypercholesterolemia | COMPLETED | PHASE2 | 2012-12 | 2013-08 | 2013-08 |
| NCT01751984 | A Study of the Efficacy and Safety of ETC-1002 in Participants With Statin Intolerance | COMPLETED | PHASE2 | 2012-10-04 | 2013-05-01 | 2013-05-01 |
| NCT01607294 | A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 Diabetes | COMPLETED | PHASE2 | 2012-04 | 2012-10 | 2012-10 |
| NCT01485146 | A Multiple Ascending Dose Study of ETC-1002 in Healthy Subjects | COMPLETED | PHASE1 | 2011-10-25 | 2012-01-25 | 2012-01-25 |
| NCT01262638 | A Study to Assess the Efficacy and Safety of ETC-1002 in Subjects With Elevated Blood Cholesterol and Either Normal or Elevated Triglycerides | COMPLETED | PHASE2 | 2010-12 | 2011-08-23 | 2011-08-23 |
| NCT01105598 | A Multiple Ascending Dose Study of ETC-1002 in Subjects With Mild Dyslipidemia | COMPLETED | PHASE1 | 2010-04-20 | 2010-10-02 | 2010-10-02 |